RCUS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

RCUSArcus Biosciences, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

RCUSArcus Biosciences, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RCUS 7

GILDGileadsupplier

AZNAstraZenecasupplier

—WuXi Biologics Irelandunlistedsupplier

—Abmuno Therapeuticsunlistedsupplier

3 more · RCUS chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

RCUSArcus Biosciences, Inc.

17.69· pre 17.30· delayed

Mkt cap$2.5BRevenue$9MQ3 FY26Revenue$247MFY25

LLYELI Lilly & Co

1,371.32· pre 1,350.00· delayed

Pre-marketNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 6 '26delayed

RCUSArcus Biosciences, Inc.

LLYELI Lilly & Co

17.69pre 17.30delayed

Price

1,371.32pre 1,350.00delayed

$2.5B

Mkt cap

$1.2T

Q3 FY26$9M

Revenue

$24.4BQ3 FY26

FY25$247M

Revenue

$65.2BFY25

RCUS17.69vsLLY1,371.32Pre-marketNov 6 '26delayed